Activity of cabozantinib (cabo) after PD-1/PD-L1 immune checkpoint blockade (ICB) in metastatic clear cell renal cell carcinoma (mccRCC)
2018 ◽
Vol 29
◽
pp. viii311
◽
B.A. McGregor
◽
A.-K. Lalani
◽
W. Xie
◽
J.A. Steinharter
◽
D.J. Martini
◽
...
2020 ◽
Vol 12
(19)
◽
pp. 19316-19324
Pengju Li
◽
Jeifei Xiao
◽
Bangfen Zhou
◽
Jinhuan Wei
◽
Junhang Luo
◽
...
Natalia Miheecheva
◽
Yang Lyu
◽
Akshaya Ramachandran
◽
Danil Stupichev
◽
Alexander Bagaev
◽
...
2020 ◽
Vol 135
◽
pp. 203-210
◽
Bradley A. McGregor
◽
Aly-Khan A. Lalani
◽
Wanling Xie
◽
John A. Steinharter
◽
Ziad E. Bakouny
◽
...
2021 ◽
Vol 32
◽
pp. S1368
C.E. Nunes-Xavier
◽
M. Emaldi
◽
T. Øyjord
◽
G. Larrinaga
◽
P. Errarte
◽
...
2018 ◽
Vol 359
(6377)
◽
pp. 801-806
◽
Diana Miao
◽
Claire A. Margolis
◽
Wenhua Gao
◽
Martin H. Voss
◽
Wei Li
◽
...
2019 ◽
Vol 380
(26)
◽
pp. 2581-2582
◽
Jonas Sjolund
◽
David Lindgren
◽
Helén Nilsson
◽
Martin E. Johansson
◽
Hakan Axelson
◽
...
Xiaohan Zhou
◽
Wanting Hou
◽
Ling Gao
◽
Lin Shui
◽
Cheng Yi
◽
...
X. Sheng
◽
F. Gong
◽
Y. Bai